By contrast, Shh pathway-driven BCC epithelia growing within a specialized TREM1 myeloid-driven inflammatory environment are induced by the TME to undergo phenotypic switching towards the alternative BIT tumor state that possesses low hedgehog pathway signaling and distinct resistance characteristics, providing multiple avenues to thwart targeted therapy. The gene discussed is SHH; the disease is skin basal cell carcinoma.